Deep Neural Networks Improve Radiologists' Performance in Breast Cancer Screening.


Journal

IEEE transactions on medical imaging
ISSN: 1558-254X
Titre abrégé: IEEE Trans Med Imaging
Pays: United States
ID NLM: 8310780

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 12 10 2019
medline: 2 3 2021
entrez: 12 10 2019
Statut: ppublish

Résumé

We present a deep convolutional neural network for breast cancer screening exam classification, trained, and evaluated on over 200000 exams (over 1000000 images). Our network achieves an AUC of 0.895 in predicting the presence of cancer in the breast, when tested on the screening population. We attribute the high accuracy to a few technical advances. 1) Our network's novel two-stage architecture and training procedure, which allows us to use a high-capacity patch-level network to learn from pixel-level labels alongside a network learning from macroscopic breast-level labels. 2) A custom ResNet-based network used as a building block of our model, whose balance of depth and width is optimized for high-resolution medical images. 3) Pretraining the network on screening BI-RADS classification, a related task with more noisy labels. 4) Combining multiple input views in an optimal way among a number of possible choices. To validate our model, we conducted a reader study with 14 readers, each reading 720 screening mammogram exams, and show that our model is as accurate as experienced radiologists when presented with the same data. We also show that a hybrid model, averaging the probability of malignancy predicted by a radiologist with a prediction of our neural network, is more accurate than either of the two separately. To further understand our results, we conduct a thorough analysis of our network's performance on different subpopulations of the screening population, the model's design, training procedure, errors, and properties of its internal representations. Our best models are publicly available at https://github.com/nyukat/breast_cancer_classifier.

Identifiants

pubmed: 31603772
doi: 10.1109/TMI.2019.2945514
pmc: PMC7427471
mid: NIHMS1612554
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1184-1194

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB017183
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA225175
Pays : United States

Références

Sci Rep. 2018 Feb 9;8(1):2762
pubmed: 29426948
J Digit Imaging. 2017 Aug;30(4):499-505
pubmed: 28656455
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
Radiology. 2019 Feb;290(2):305-314
pubmed: 30457482
Breast Cancer Res Treat. 2015 May;151(1):19-25
pubmed: 25868866
JAMA Intern Med. 2015 Nov;175(11):1828-37
pubmed: 26414882
Acad Radiol. 2012 Feb;19(2):236-48
pubmed: 22078258
Cancer. 2002 Jan 15;94(2):580-1; author reply 581-3
pubmed: 11900247
J Natl Cancer Inst. 2019 Sep 1;111(9):916-922
pubmed: 30834436
J Med Imaging (Bellingham). 2017 Oct;4(4):044501
pubmed: 29021992
Invest Radiol. 2017 Jul;52(7):434-440
pubmed: 28212138
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Med Image Anal. 2017 Jan;35:303-312
pubmed: 27497072
Sci Rep. 2018 Mar 15;8(1):4165
pubmed: 29545529
AJR Am J Roentgenol. 2019 Feb;212(2):300-307
pubmed: 30667309
CA Cancer J Clin. 2002 Mar-Apr;52(2):68-71
pubmed: 11929006
Cancer. 2002 Aug 1;95(3):458-69
pubmed: 12209737

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH